Evidence map›Paper›PMID 29858012›Full record

ArticleImmunity2018

Transcription Factor IRF8 Orchestrates the Adaptive Natural Killer Cell Response.

Nicholas M Adams, Colleen M Lau, Xiying Fan, Moritz Rapp, Clair D Geary, Orr-El Weizman, Carlos Diaz-Salazar, Joseph C Sun

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 1 synthesis or guideline pooled it, 124 citations in OpenAlex.

  1. Pooled it
  2. Therapeutic bacteria-trained NK cells confer long-term protection against cancer metastasis.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Nicholas M AdamsImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Colleen M LauImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Xiying FanImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Moritz RappImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Clair D GearyImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Orr-El WeizmanImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Carlos Diaz-SalazarImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Joseph C SunImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Immunology and Microbial Pathogenesis, Weill Cornell Medical College, New York, NY 10065, USA. Electronic address: sunj@mskcc.org.
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
The natural killer cell response against mouse cytomegalovirus infectionR01AI100874 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI Joseph Chai-Yuen Sun · 2012 to 2026
$7.4M
IMMUNOLOGY RESEARCH TRAININGT32CA009149 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI RUDENSKY, ALEXANDER Y · 1985 to 2022
$4.0M
Regulation of Nfil3 in innate lymphocyte-mediated host immunityR01AI130043 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI SUN, JOSEPH CHAI-YUEN · 2017 to 2021
$2.8M
Function of Regulatory T Cells in Tissue RepairF30AI122721 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI FAN, XIYING · 2016 to 2019
$172k
Elucidating the function of IRF8 during antiviral natural killer cell responsesF30AI136239 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI ADAMS, NICHOLAS M · 2018 to 2019
$84k
NCI NIH HHS P30 CA008748NCI NIH HHS T32 CA009149NIAID NIH HHS F30 AI122721NIAID NIH HHS F30 AI136239NIAID NIH HHS R01 AI100874NIAID NIH HHS R01 AI130043NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

Natural killer (NK) cells are innate lymphocytes that display features of adaptive immunity during viral infection. Biallelic mutations in IRF8 have been reported to cause familial NK cell deficiency and susceptibility to severe viral infection in humans; however, the precise role of this transcription factor in regulating NK cell function remains unknown. Here, we show that cell-intrinsic IRF8 was required for NK-cell-mediated protection against mouse cytomegalovirus infection. During viral exposure, NK cells upregulated IRF8 through interleukin-12 (IL-12) signaling and the transcription factor STAT4, which promoted epigenetic remodeling of the Irf8 locus. Moreover, IRF8 facilitated the proliferative burst of virus-specific NK cells by promoting expression of cell-cycle genes and directly controlling Zbtb32, a master regulator of virus-driven NK cell proliferation. These findings identify the function and cell-type-specific regulation of IRF8 in NK-cell-mediated antiviral immunity and provide a mechanistic understanding of viral susceptibility in patients with IRF8 mutations.

Indexed as

Adaptive ImmunityAnimalsHerpesviridae InfectionsInterferon Regulatory Factor-8Interferon Regulatory FactorsKiller Cells, NaturalLymphocyte ActivationMiceMuromegalovirusInterferon Regulatory Factor-8Interferon Regulatory FactorsIRF8MCMVNK cellstranscriptional regulationviral infection

Identifiers

PMID29858012
PMCPMC6233715
OpenAlexW2806582733

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.